Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Outcome Of The Board Meeting Held On Thursday, February 11, 2021

In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we have to inform you that the Board of Directors of the Company, in their meeting held today i.e. Thursday, February 11, 2021 has inter-alia approved the Un-Audited Financial Results on Standalone basis for the quarter ended December 31, 2021 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations. The meeting of Board of Directors commenced at 12:00 P.M. and concluded at 3:30 P.M.
11-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 10, 2021 for Shree Rasbihari Trading & Investment Pvt Ltd
11-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 10, 2021 for Raj Exports Pvt Ltd
11-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 09, 2021 for Shree Rasbihari Trading & Investment Pvt Ltd
10-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 09, 2021 for Raj Exports Pvt Ltd
10-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 09, 2021 for Ajay R Dhoot
10-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 09, 2021 for Aditya R Dhoot
10-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Board Meeting To Be Held On Thursday, February 11, 2021.

MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended December 31, 2020.
03-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholding for the Period Ended December 31, 2020

Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
09-01-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended December 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Geeta G KariraDesignation :- Company Secretary and Compliance Officer
06-01-2021
Next Page
Close

Let's Open Free Demat Account